Highlights
nlEuropean Immunization Week 2019: statement by Executive Director Guido Rasi, , 24/04/2
nlnl nl nlnlVaccine-preventable diseases are making a comeback in Europe. Let’s t
Infant death in trial yet Novartis anticipates no threat to approval
Novartis investigates the death of an infant in a gene therapy clinical trial to determine whether it was related to the
AbbVie gets nod for psoriasis drug ahead of Humira patent cliff
AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humir
Laser Wire Solutions wins Queen’s Award for Innovation
Laser Wire Solutions has been awarded the Queen’s Award for Innovation for its pinpoint accurate technology which
Protolabs announces collaboration with Cleveland Clinic Healthcare Innovations Alliance
Protolabs are collaborating with the Cleveland Clinic Healthcare Innovations Alliance on an awards programme which ai
Scholars International Conference on Pediatrics and Neonatology
Scholars Conferences is proud to present the highly anticipated “Scholars International Conference on Pediatrics a
Meet at Med-Tech Innovation Expo: Oliver Healthcare Packaging
Oliver Healthcare Packaging is inviting visitors to learn more about CleanCut Technologies at the Med-Tech Innovation Ex
Perforce Software: Medical Device Industry Survey Reveals 75% Satisfaction With Hybrid Dev
Survey of 270 professionals shows only 38% “Very confident” they could pass a surprise audit; productivity a
The small print: A 3D bioprinter is now present in Queen's University Belfast
Queen's University Belfast has invested in a 3D bioprinter from GeSiM for research into the manufacture of medical d
Are plastics that are used within the healthcare sector being recycled?
Ole Grøndahl Hansen, project manager of PVCMed Alliance, discusses how plastics have paved the way for significantly
Road to recovery: Why manufacturers need to ensure their processes meet agreed protocols
Lucy Pamment, a supply chain technology specialist for Access Group, believes the recent Implant Files scandal will put
FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis
NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (F